View Author
patient mutation sample ficiency syndrome ficiency glut 1 protein syndrome study phenotype university concentration department 1– glucose table disease dementia laboratory slc 2a gene neurology analysis level erasmus university rotterdam group disorder alzheimer diagnosis cerebrospinal fl uid brain tyrosine plasma hydroxylase cancer tyrosine hydroxylase number breast cancer 1– 42 movement ketogenic diet 1– 40 peptide dystonia reference identi fied difference month ratio protein concentration centre biomarker erasmu result hospital l-dopa identi assay netherland non-classical phenotype elisa model blood glucose ratio value breast p.arg amyloid movement disorders onset type b patients rotterdam novel peak positions downloaded paediatric proteomic position person blood retardation family
7 Most Recent Publications
|
Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome
(Article)
Coppus, A.M.W. Schuur, M. Vergeer, J. Janssens, A.C.J.W. Oostra, B.A. Verbeek, M.M. Tikka-Kleemola, P. |
2011-10-05
|
|
Tyrosine hydroxylase deficiency: A treatable disorder of brain catecholamine biosynthesis
(Article)
Willemsen, M.A. Verbeek, M.M. Haeussler, M. Hoffmann, G.F. Jung, H. Klerk, J.B.C. de Knaap, M.S. van der Kok, F. Leuzzi, V. Lonlay, P. de Megarbane, A. Monaghan, H. Kamsteeg, E.J. Renier, W.O. Rondot, P. Ryan, M.M. Seeger, J. Smeitink, J.A.M. Steenbergen-Spanjers, G.C. Wassmer, E. Weschke, B. Wijburg, F.A. Wilcken, B. Rijk-Van Andel, J.F. de Zafeiriou, D.I. Wevers, R.A. Aeby, A. Blau, N. Burlina, A.B. Donati, M.A. Geurtz, B. Grattan-Smith, P.J. |
2010-06-01
|
|
Glucose transporter-1 deficiency syndrome: The expanding clinical and genetic spectrum of a treatable disorder
(Article)
Leen, W.G. Klepper, J. Bekhof, J. Bogaert, P. van Carrilho, I. Chabrol, B. Champion, M.P. Coldwell, J. Clayton, P. Donner, E. Evangeliou, A. Ebinger, F. Verbeek, M.M. Farrell, K. Forsyth, R.J. Goede, C.G.E.L. de Gross, S. Grünewald, S. Holthausen, H. Jayawant, S. Lachlan, K. Laugel, V. Leppig, K. Leferink, M. Lim, M.J. Mancini, G.M.S. Marina, A.D. Martorell, L. McMenamin, J. Meuwissen, M.E.C. Mundy, H. Nilsson, N.O. Panzer, A. Poll-The, B.T. Hofste, T. Rauscher, C. Rouselle, C.M.R. Sandvig, I. Scheffner, T. Sheridan, E. Simpson, N. Sykora, P. Tomlinson, R. Trounce, J. Webb, D. Engelen, B.G. van Weschke, B. Scheffer, H. Willemsen, M.A. Wevers, R.A. Arthur, T. Bahi-Buisson, N. Ballhausen, D. |
2010-03-01
|
|
Neurofilament ELISA validation
(Article)
Petzold, A. Altintas, A. Constantinescu, C.S. Deisenhammer, F. Deniz, G. Erten, G. Espiño, M. Fainardi, E. Franciotta, D. Freedman, M.S. Giedraitis, V. Gilhus, N.E. Andreoni, L. Giovannoni, G. Glabinski, A. Grieb, P. Hartung, H.P. Hemmer, B. Herukka, S.K. Hintzen, R.Q. Ingelsson, M. Jackson, S. Jacobsen, S. Bartos, A. Jafari, N. Jalosinski, M. Jarius, S. Kapaki, E. Kieseier, B.C. Koel-Simmelink, M.J.A. Kornhuber, J. Kuhle, J. Kurzepa, J. Lalive, P.H. Berthele, A. Lannfelt, L. Lehmensiek, V. Lewczuk, P. Livrea, P. Marnetto, F. Martino, D. Menge, T. Norgren, N. Papuć, E. Paraskevas, G.P. Blankenstein, M.A. Pirttilä, T. Rajda, C. Rejdak, K. Ricny, J. Ripova, D. Rosengren, L. Ruggieri, M. Schraen, S. Shaw, G. Sindic, C. Buee, L. Siva, A. Stigbrand, T. Stonebridge, I. Topcular, B. Trojano, M. Tumani, H. Twaalfhoven, H.A.M. Vécsei, L. Pesch, V. van Vanderstichele, H.M.J. Castellazzi, M. Vedeler, C. Verbeek, M.M. Villar, L.M. Weissert, R. Wildemann, B. Yang, C. Yao, K. Teunissen, C.E. Cepok, S. Comabella, M. |
2010-01-31
|
|
CSF studies facilitate DNA diagnosis in familial alzheimer's disease due to a presenilin-1 mutation
(Article)
Bot, S.T. de Kremer, H.P. Dooijes, D. Verbeek, M.M. |
2009-07-27
|
|
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
(Article)
Verwey, N.A. Flier, W.M. van der Lannfelt, L. Mehta, P.D. Parnetti, L. Petzold, A. Pirttilä, T. Saleh, L. Skinningsrud, A. Swieten, J.C. van Verbeek, M.M. Wiltfang, J. Blennow, K. Younkin, S. Scheltens, P. Blankenstein, M.A. Clark, C. Sokolow, S. Deyn, P.P. de Galasko, D. Hampel, H. Hartmann, J.T. Kapaki, E. |
2009-05-01
|
|
MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.
(Article)
Dekker, L.J.M. Boogerd, W. Luider, T.M. Smitt, P.A. Stockhammer, G. Dalebout, J.C. Siccama, I. Zheng, P.P. Bonfrer, J.M. Verschuuren, J.J. Jenster, G.W. Verbeek, M.M. |
2005-09-01
|